back to top
My wish lists
Save your wish list
If you want to add more content to your wish list, simply log in. If you do not have a user account, please register for the Hanser Customer Center.

» Do you already have a user account? Please log in here.
» Don't have a user account yet? Please register here.
Your wish lists
If you want to use your wish list during your next visit, simply log in. If you do not have a user account, please register for the Hanser Customer Center.
» Do you already have a user account? Please log in here.
» Don't have a user account yet? Please register here.

« Back

Your advantages at a glance

  • One login for all Hanser portals
  • Individual home page for faster access to preferred content
  • Exclusive access to selected content
  • Personal wish lists on all portals
  • Central management of your personal information and newsletter subscriptions

Register now
Deutsch
Bookmark Bookmarked
08-25-2017

Röchling Group Names New CEO

Prof. Dr. Hanns-Peter Knaebel (© Röchling)

Prof. Dr. Hanns-Peter Knaebel will be the new CEO of Röchling SE & Co. KG, Mannheim, Germany. On October 1, 2017, he will join the Executive Board of the Röchling Group and be in charge of Medicine as Deputy Chairman. On January 1, 2018, Knaebel will then take on the position of CEO, as Ludger Bartels (64) will be retiring at the turn of the year.

Hanns-Peter Knaebel (48) has a PhD in medicine worked for 12 years at the Department of Surgery at Heidelberg University Hospital. He played a major role in building up the Clinical Study Center of the Department of Surgery at Heidelberg University Hospital and the study center of the German Surgical Society. From 2004 to 2006, parallel to his work he studied for a degree in economics at the University of Salzburg, Austria, which he completed with a Master’s of Business Administration (MBA). In the same year, he qualified as professor at the University of Heidelberg’s Medical Faculty. In 2007, Knaebel became the head of the Clinical Science department at Aesculap. Five months later, he was entrusted with global responsibility for Marketing and Sales. In 2008, Prof. Knaebel was appointed as a member of the Executive Board of Aesculap AG and was its Chairman from 2009 onwards. He represented Aesculap as a member of the Executive Board of the family-owned company B. Braun Melsungen AG, a medical technology manufacturer.

Röchling is delighted to have Knaebel on board as an experienced and innovative business leader and renowned medical technician. This is because medical technology is the most significant strategic growth segment for the Röchling Group. Erwin Doll (Automotive), Franz Lübbers (Industrial), Steffen Rowold (Finance) and Ludger Bartels (as CEO until the turn of the year) will remain members of Röchling’s Executive Board alongside Knaebel.

Company profile

Röchling SE & Co. KG

Richard-Wagner-Str. 9
DE 68165 Mannheim
Tel.: 0621 44055-0
Fax: 0621 44055-355

Newsletter

Would you like to subscribe to our Newsletters on plastics technology and profit from the latest information?

Subscribe here

Subscribe here

Job Advertisements

Looking for a new challenge? Check out our jobs market!

Job Advertisements

Patents Stimulate Innovation

Patents encourage innovation: Stay on the ball with the latest innovations in the plastics industry in our patents section.

Patents